The U.S. Judicial Panel on Multidistrict Litigation has picked New Jersey as the site to consolidate suits nationwide linking cancer to usage of talcum powder.
The Oct. 4 order transferred 11 pending cases and 43 more potential actions from around the country to U.S. District Judge Freda Wolfson of the District of New Jersey. Wolfson presides over Chakalos v. Johnson & Johnson, which was filed in November 2014, making it the most advanced suit of its kind in the nation. Her experience with that case makes her well-situated to structure the litigation to minimize delay and avoid duplication of discovery and motion practice, the panel said. Furthermore, New Jersey is the best venue for the suits because it is home to Johnson & Johnson, a defendant in the litigation, so that relevant witnesses and evidence are likely located in the state, the panel said.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
